JANX - Financial Reports List - Janux Therapeutics, Inc. - IntrinsicAlpha

Janux Therapeutics, Inc. JANX

Healthcare - Biotechnology - NASDAQ - US

$ 29.3

-1.31 %

$ 1.73 B

Market Cap

-22.89

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-71.93%	-79.85%
Annual Report	FY	10-K	2024-12-31	30.99%	-18.36%	-35.45%
Quarterly Report	Q3	8-K	2024-09-30	-82.56%	-142.56%	-126.66%
Quarterly Report	Q2	8-K	2024-06-30	741.72%	65.96%	33.38%
Quarterly Report	Q1	8-K	2024-03-31	-38.87%	15.46%	0.59%
Quarterly Report	Q4	8-K	2023-12-31	-13.50%	26.81%	11.66%
Annual Report	FY	10-K	2023-12-31	-6.14%	-7.64%	-8.78%
Quarterly Report	Q3	8-K	2023-09-30	38.83%	17.63%	12.26%
Quarterly Report	Q2	8-K	2023-06-30	-55.31%	-6.01%	-20.20%
Quarterly Report	Q1	8-K	2023-03-31	28.89%	-32.81%	-49.76%

1